(Q38698442)

English

Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26773297%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26773297%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

steatohepatitis

0 references

inflammasome complex

1 reference

based on heuristic

inferred from title

alcoholic hepatitis

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

Alexander R Moschen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26773297%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Herbert Tilg

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26773297%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Gyongyi Szabo

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26773297%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

language of work or name

0 references

publication date

9 March 2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26773297%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26773297%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

64

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26773297%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26773297%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

955-965

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26773297%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Nucleotide sequence of human monocyte interleukin 1 precursor cDNA

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Immunological and inflammatory functions of the interleukin-1 family

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Anti-inflammatory Agents: Present and Future

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

The IL-1 family: regulators of immunity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

The interleukin-1 family: back to the future

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Inflammasomes in liver diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

IL-1α and IL-1β recruit different myeloid cells and promote different stages of sterile inflammation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Sterile inflammation in the liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Cytokines in alcoholic and nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Inflammatory mechanisms in the regulation of insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Inflammasome activation and function in liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Caspase-1: is IL-1 just the tip of the ICEberg?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

IL-1 signaling in obesity-induced hepatic lipogenesis and steatosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Interleukin-1 participates in the progression from liver injury to fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Essential Role of Matrix Metalloproteinases in Interleukin-1-induced Myofibroblastic Activation of Hepatic Stellate Cell in Collagen

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

IL-1beta-induced increase in intestinal epithelial tight junction permeability is mediated by MEKK-1 activation of canonical NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Identification of a key pathway required for the sterile inflammatory response triggered by dying cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Detection and characterization of IL-1 receptor antagonist in tissues from healthy rabbits: IL-1 receptor antagonist is probably involved in health.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Serum interleukin-1 (IL-1) activity in alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Gene expression of interleukin 18 in unstimulated peripheral blood mononuclear cells of patients with alcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Imbalance of IL-1 beta and IL-1 receptor antagonist mRNA in liver tissue from hepatitis C virus (HCV)-related chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1β in mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Metabolic danger signals, uric acid and ATP, mediate inflammatory cross-talk between hepatocytes and immune cells in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: a critical role for E-selectin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Chronic ethanol consumption enhances interleukin-1-mediated signal transduction in rat liver and in cultured hepatocytes.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Nuclear factor-eythroid 2-related factor 2 prevents alcohol-induced fulminant liver injury

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Inhibition of sterile danger signals, uric acid and ATP, prevents inflammasome activation and protects from alcoholic steatohepatitis in mice.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Gaps in Knowledge and Research Priorities for Alcoholic Hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Mechanism of interleukin-1β induced-increase in mouse intestinal permeability in vivo

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Adipose and liver expression of interleukin (IL)-1 family members in morbid obesity and effects of weight loss

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

What we talk about when we talk about fat.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Circulating levels of interleukin-1 family cytokines in overweight adolescents.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

IL-37 is a fundamental inhibitor of innate immunity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Interleukin-1β regulates fat-liver crosstalk in obesity by auto-paracrine modulation of adipose tissue inflammation and expandability

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Attenuation of inflammation and cellular stress-related pathways maintains insulin sensitivity in obese type I interleukin-1 receptor knockout mice on a high-fat diet.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Interleukin-18 protein level is upregulated in adipose tissue of obese mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Long-term weight loss decreases the nontraditional cardiovascular risk factors interleukin-18 and matrix metalloproteinase-9 in obese subjects.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

NLRP3 inflammasome activation is required for fibrosis development in NAFLD.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Peroxisome proliferator-activated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Role of peroxisome proliferator-activated receptor {delta}/{beta} in hepatic metabolic regulation.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Anakinra for rheumatoid arthritis: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

21 January 2018

Alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum levels of cytokines in chronic liver diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased plasma tumor necrosis factor in severe alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating concentrations of interleukin-18, interleukin-18 binding protein, and gamma interferon in patients with alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

7 January 2021

based on heuristic

inferred from DOI database lookup

Impaired counter-regulation of interleukin-1 by the soluble IL-1 receptor type II in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibiotics prevent liver injury in rats following long-term exposure to ethanol

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

7 January 2021

based on heuristic

inferred from DOI database lookup

IL-1 cytokine family members and NAFLD: neglected in metabolic liver inflammation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

7 January 2021

based on heuristic

inferred from DOI database lookup

IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

7 January 2021

based on heuristic

inferred from DOI database lookup

Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of interleukin-1α in Kupffer cells attenuates liver inflammation and expression of inflammatory cytokines in hypercholesterolaemic mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of apolipoprotein A5 in non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

7 January 2021

based on heuristic

inferred from DOI database lookup

Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28456

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.28456

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26773297%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26773297%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38698442&oldid=2088700434"